|
Discovery to hasten new malaria treatments, vaccines for children
April 24, 2008TALLAHASSEE, Fla. -- April 25 is World Malaria Day 2008 and despite the grim statistics out of Africa there's cause for celebration. Florida State University biologists have discovered an autoimmune-like response in blood drawn from malaria-infected African children that helps to explain why existing DNA-based anti-malaria vaccines have repeatedly failed to protect them.
The groundbreaking study is expected to speed and better inform the development of new treatments and vaccines that effectively target the unique medical needs of malaria's smallest, most vulnerable victims.
FSU's research -- which focused on children in remote Nigerian villages who were younger than 6 and infected with Plasmodium falciparum, the most virulent form of the malarial parasite -- has shed much-needed light on heretofore poorly understood remnants of white blood cells that have long been known to circulate in malaria victims' blood but were thought to be debris.
Researchers from FSU's Department of Biological Science were the first to observe that the white blood cell remnants actually are Neutrophil Extracellular Traps or "NETs" that both capture malaria parasites and engender unique, often deadly responses in the immune systems of very young children. As a result, they are far more likely to develop severe, coma-inducing malaria and die than are adults who may carry higher levels of the parasite but have survived repeated infections.
Those findings are described in the February 2008 edition of the journal Malaria. The paper was co-authored by FSU Associate Professor Tom Keller, Professor Ken Roux and graduate research assistant Pallavi Tawde and led by Keller's then-doctoral student Virginia Baker, now an assistant professor at Chipola College in Marianna, Fla.
The FSU news has emerged amid worsening data on malaria's human and economic costs. Described 4,700 years ago in ancient Chinese medical writings and by the Greek physician Hippocrates in the 4th-century B.C.E., malaria today still sickens and kills more children in Africa -- where more than 90 percent of all cases of malaria occur -- than almost any other cause.
To better understand why children are so sensitive and to look for clues to why adults become resistant to malaria infection, the FSU researchers measured the levels of cytokines -- molecules that are released in response to infection and circulate in the blood stream to function as signals in the immune system -- both before and after the children were treated with an effective anti-malarial drug.
"We also took a fresh look at some unusual white blood cells that appeared to have exploded in the children's blood smears," Keller said. "Although scientists had observed these structures for years in malaria-infected blood samples, they remained very poorly understood.
"From our interpretations of the existing literature, we suspected that an autoimmune-like response may have contributed to the severity of malaria in young children," he said. "Nevertheless, we were completely surprised to find that the strange white blood cell structures characterized by previous researchers as artifacts or an extraordinary response to other types of infections were in fact circulating 'NETs' of DNA, which form as a result of the immune system's response to malaria."
Consequently, said Baker, protocols designed to treat the accompanying autoimmune-like response will be more effective in preventing severe malaria in young children than treatments directed only at clearing the parasites.
In 2004, as a graduate student with extensive field and laboratory experience in the diagnosis and treatment of Asian malaria, Baker organized the FSU study and spent several weeks in Nigeria directing the sample collection by Nigerian medical collaborators. The samples were shipped to the United States and analyzed at FSU between 2005-2007. The 2008 paper, "Cytokine-associated Neutrophil Extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age," is accessible online at http://www.malariajournal.com/articles/browse.asp.
A grant from the World Health Mission funded the FSU study, which included the distribution of insecticide-treated mosquito nets and anti-malarial drugs to Nigerian villages.
The Sunshine State could well become an unexpected beneficiary of FSU's research.
"Whenever a vector, such as a mosquito, can carry a life-threatening illness, it becomes of interest closer to home, especially when the disease affects American travelers who may unwittingly carry the disease to U.S. soil," Keller said. "The State of Florida has all the necessary constituents to sustain the malaria life cycle, and the functional immune system found in the typical American is in no way primed to defend itself against the relentless cellular destruction incurred by the falciparum malaria parasite. We'd all have reason to celebrate the advent of better treatments and an effective vaccine."
Florida State University
Researchers from FSU's Department of Biological Science were the first to observe that the white blood cell remnants actually are Neutrophil Extracellular Traps or "NETs" that both capture malaria parasites and engender unique, often deadly responses in the immune systems of very young children. As a result, they are far more likely to develop severe, coma-inducing malaria and die than are adults who may carry higher levels of the parasite but have survived repeated infections.
Those findings are described in the February 2008 edition of the journal Malaria. The paper was co-authored by FSU Associate Professor Tom Keller, Professor Ken Roux and graduate research assistant Pallavi Tawde and led by Keller's then-doctoral student Virginia Baker, now an assistant professor at Chipola College in Marianna, Fla.
The FSU news has emerged amid worsening data on malaria's human and economic costs. Described 4,700 years ago in ancient Chinese medical writings and by the Greek physician Hippocrates in the 4th-century B.C.E., malaria today still sickens and kills more children in Africa -- where more than 90 percent of all cases of malaria occur -- than almost any other cause.
To better understand why children are so sensitive and to look for clues to why adults become resistant to malaria infection, the FSU researchers measured the levels of cytokines -- molecules that are released in response to infection and circulate in the blood stream to function as signals in the immune system -- both before and after the children were treated with an effective anti-malarial drug.
"We also took a fresh look at some unusual white blood cells that appeared to have exploded in the children's blood smears," Keller said. "Although scientists had observed these structures for years in malaria-infected blood samples, they remained very poorly understood.
"From our interpretations of the existing literature, we suspected that an autoimmune-like response may have contributed to the severity of malaria in young children," he said. "Nevertheless, we were completely surprised to find that the strange white blood cell structures characterized by previous researchers as artifacts or an extraordinary response to other types of infections were in fact circulating 'NETs' of DNA, which form as a result of the immune system's response to malaria."
Consequently, said Baker, protocols designed to treat the accompanying autoimmune-like response will be more effective in preventing severe malaria in young children than treatments directed only at clearing the parasites.
In 2004, as a graduate student with extensive field and laboratory experience in the diagnosis and treatment of Asian malaria, Baker organized the FSU study and spent several weeks in Nigeria directing the sample collection by Nigerian medical collaborators. The samples were shipped to the United States and analyzed at FSU between 2005-2007. The 2008 paper, "Cytokine-associated Neutrophil Extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age," is accessible online at http://www.malariajournal.com/articles/browse.asp.
A grant from the World Health Mission funded the FSU study, which included the distribution of insecticide-treated mosquito nets and anti-malarial drugs to Nigerian villages.
The Sunshine State could well become an unexpected beneficiary of FSU's research.
"Whenever a vector, such as a mosquito, can carry a life-threatening illness, it becomes of interest closer to home, especially when the disease affects American travelers who may unwittingly carry the disease to U.S. soil," Keller said. "The State of Florida has all the necessary constituents to sustain the malaria life cycle, and the functional immune system found in the typical American is in no way primed to defend itself against the relentless cellular destruction incurred by the falciparum malaria parasite. We'd all have reason to celebrate the advent of better treatments and an effective vaccine."
Florida State University
Malaria News and Current Malaria Events RSSStudy shows male homosexuality can be explained through a specific model of Darwinian evolution
Reporting in this week's PLoS ONE, an Italian research team, consisting of Andrea Camperio Ciani and Giovanni Zanzotto at the University of Padova and Paolo Cermelli at the University of Torino, found that the evolutionary origin and maintenance of male homosexuality in human populations could be explained by a model based around the idea of sexually antagonistic selection, in which genetic factors spread in the population by giving a reproductive advantage to one sex while disadvantaging the other.
New molecular insight into amboebic dysentery
In the June 15th issue of G&D, Dr. Sinisa Urban (Johns Hopkins University School of Medicine) and colleagues reveal a potential role for the rhomboid enzyme, EhROM1, in the pathogenesis of the enteric protozoan parasite, E. histolytica.
Radical reform is needed to stop the 'inhumane' practice of transplant tourism
The UK government must bring in presumed consent to organ donation or allow a controlled donor compensation programme for unrelated live donors, in order to bring the "inhumane" practice of transplant tourism from the UK to an end, claims a doctor in this week's BMJ.
How Montezuma gets his revenge
Every year, about 500 million people worldwide are infected with the parasite that causes dysentery, a global medical burden that among infectious diseases is second only to malaria.
Taking the temperature of the no-fly zone
Flies, unlike humans, can't manipulate the temperature of their surroundings so they need to pick the best spot for flourishing. New Brandeis University research in this week's Nature reveals that they have internal thermosensors to help them.
Researchers block the transmission of malaria in animal tests
By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent the malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.
Persistent Man-made Chemical Pollutants Found in Deep-sea Octopods and Squids
New evidence that chemical contaminants are finding their way into the deep-sea food web has been found in deep-sea squids and octopods, including the strange-looking "vampire squid". These species are food for deep-diving toothed whales and other predators.
Findings offer insights into role of breastfeeding in preventing infant death, HIV infection
In many poor countries, mothers with HIV face a stark choice: to nurse their infants, and risk passing on HIV through their breast milk-or to formula feed, and deprive their infants of much of the natural immunity needed to protect against fatal diseases of early infancy.
Virginia Tech researchers find human virus in chimpanzees
After studying chimpanzees in the wilds of Tanzania's Mahale Mountains National Park for the past year as part of a National Science Foundation (NSF) grant, Virginia Tech researcher Dr. Taranjit Kaur and her team have produced powerful scientific evidence that chimpanzees are becoming sick from viral infectious diseases they have likely contracted from humans.
Scientists demonstrate feasibility of preventing malaria parasite from becoming sexually mature
Researchers have demonstrated the possibility of preventing the human malaria parasite, Plasmodium falciparum, which is responsible for more than a million malaria deaths a year, from becoming sexually mature.
More Malaria News Articles
 | The Coconut Oil Miracle (Previously published as The Healing Miracle of Coconut Oil) by Bruce Fife, Jon J. Kabara |
 | Generation Change: Roll Up Your Sleeves and Change the World (Invert) by Zach Hunter |
 | The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard |
 | The Malaria Capers : More Tales of Parasites and People, Research and Reality by Robert S. Desowitz |
 | Malaria Dreams: An African Adventure by Stuart Stevens |
 | Quinine: Malaria and the Quest for a Cure That Changed the World by Fiammetta Rocco |
 | The Use of the Herb Artemisinin for Babesia, Malaria, and Cancer: All the Practical Information You Need to Make Smart Decisions on Artemisinin by James Schaller |
 | Essential Malariology by David A. Warrell, Herbert M. Gilles |
 | Artemisinin, Artesunate, Artemisinic Acid and Other Derivatives of Artemisia Used for Malaria, Babesia and Cancer by James Schaller |
 | The Conquest of Malaria: Italy, 1900-1962 by Frank Snowden |
| © 2008 BrightSurf.com |